Consumer Health News and Research

RSS
Pfizer issues statement on FDA approval of non-prescription drug, Nexium 24HR

Pfizer issues statement on FDA approval of non-prescription drug, Nexium 24HR

BioRestorative Therapies, Rohto sign Research and Development Agreement

BioRestorative Therapies, Rohto sign Research and Development Agreement

Communispace launches new business unit for health care companies

Communispace launches new business unit for health care companies

Merck Millipore announces joint development agreement with Sysmex Corporation

Merck Millipore announces joint development agreement with Sysmex Corporation

Bristol-Myers Squibb, Pfizer announce FDA approval of Eliquis for DVT prophylaxis

Bristol-Myers Squibb, Pfizer announce FDA approval of Eliquis for DVT prophylaxis

Connecticut Children's OCCH receives $1M grant to address critical public health issues for children

Connecticut Children's OCCH receives $1M grant to address critical public health issues for children

FDA approves sNDA to include radiographic data updating label of Pfizer XELJANZ for treatment of RA

FDA approves sNDA to include radiographic data updating label of Pfizer XELJANZ for treatment of RA

Prevently.com: New portal aims to help people live healthier lifestyle

Prevently.com: New portal aims to help people live healthier lifestyle

UnitedHealthcare, Konami bring DDR CE Classroom Edition "exergame" to Boys & Girls Club of Southern Nevada

UnitedHealthcare, Konami bring DDR CE Classroom Edition "exergame" to Boys & Girls Club of Southern Nevada

Validic Labs launched to bridge the gap between healthcare companies and mHealth data producers

Validic Labs launched to bridge the gap between healthcare companies and mHealth data producers

CVS' tobacco move brings praise, analysis as marketing move

CVS' tobacco move brings praise, analysis as marketing move

Therapath signs contract with United Healthcare to provide neuropathology services

Therapath signs contract with United Healthcare to provide neuropathology services

Pfizer announces results from Phase 3 study of ALO-02 in patients with chronic low back pain

Pfizer announces results from Phase 3 study of ALO-02 in patients with chronic low back pain

Takeda expands commercial platform in Israel

Takeda expands commercial platform in Israel

TELUS Health to offer Medworxx Patient Flow Platform to customers

TELUS Health to offer Medworxx Patient Flow Platform to customers

Virginia Health Information publishes 2013 Health Care Pricing Report

Virginia Health Information publishes 2013 Health Care Pricing Report

Silverlink, UnitedHealthcare recognized for increasing colorectal cancer screenings among minorities

Silverlink, UnitedHealthcare recognized for increasing colorectal cancer screenings among minorities

Pfizer's Polish subsidiary acquires rights to Polocard from ZF Polpharma SA

Pfizer's Polish subsidiary acquires rights to Polocard from ZF Polpharma SA

State exchange news: Oregon's 'epic failure'; Kansas' next steps on canceled policies; rural challenge in Minnesota

State exchange news: Oregon's 'epic failure'; Kansas' next steps on canceled policies; rural challenge in Minnesota

Health law outreach efforts try new controversial ads, enrollment tactics

Health law outreach efforts try new controversial ads, enrollment tactics

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.